Other
Standard-of-Care Therapy
Standard-of-Care Therapy is an intervention with 3 clinical trials. Currently 2 active trials ongoing.
Total Trials
3
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Active Trials
2(67%)
Phase Distribution
Ph not_applicable
2
67%
Ph phase_2
1
33%
Phase Distribution
0
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
N/ANon-phased studies
2(66.7%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
0.0%
0 of 1 finished
Non-Completion Rate
100.0%
1 ended early
Currently Active
2
trials recruiting
Total Trials
3
all time
Status Distribution
Active(2)
Terminated(1)
Detailed Status
Withdrawn1
Active, not recruiting1
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
2
Success Rate
N/A
Most Advanced
Phase 2
Trials by Phase
Phase 21 (33.3%)
N/A2 (66.7%)
Trials by Status
withdrawn133%
active_not_recruiting133%
recruiting133%
Recent Activity
2 active trials
Showing 3 of 3
recruitingnot_applicable
Evaluation of a Diagnostic Test to Identify the Best Drugs for Treatment of Metastatic Colorectal Cancer
NCT07171554
active_not_recruitingphase_2
Initiative for Molecular Profiling and Advanced Cancer Therapy (IMPACT II)
NCT02152254
withdrawnnot_applicable
Sit-to-Stand Progression Using Movi Chair vs Traditional Practices
NCT03103464
Clinical Trials (3)
Showing 3 of 3 trials
NCT07171554Not Applicable
Evaluation of a Diagnostic Test to Identify the Best Drugs for Treatment of Metastatic Colorectal Cancer
NCT02152254Phase 2
Initiative for Molecular Profiling and Advanced Cancer Therapy (IMPACT II)
NCT03103464Not Applicable
Sit-to-Stand Progression Using Movi Chair vs Traditional Practices
All 3 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 3